Initial Statement of Beneficial Ownership

FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Greer Lawrence W

2. Date of Event Requiring Statement (MM/DD/YYYY)
8/10/2009 

3. Issuer Name and Ticker or Trading Symbol

CUMBERLAND PHARMACEUTICALS INC [CPIX]

(Last)        (First)        (Middle)

2525 WEST END AVE., SUITE 950

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

NASHVILLE, TN 37203       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   66272   D    
Common Stock   613248   I   Held by S.C.O.U.T. Healthcare Fund, L.P.   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options   1/4/2002   1/4/2012   Common Stock   8000   $1.63   D    
Options   5/19/2002   5/19/2011   Common Stock   7400   $1.63   D    
Options   8/31/2002   5/1/2012   Common Stock   2534   $3.13   D    
Options   12/31/2002   5/1/2012   Common Stock   2534   $3.13   D    
Options   4/30/2003   5/1/2012   Common Stock   2532   $3.13   D    
Options   11/15/2003   11/15/2013   Common Stock   14000   $6.00   D    
Options   12/31/2005   12/31/2015   Common Stock   15000   $9.00   D    
Options   5/24/2004   5/24/2014   Common Stock   43120   $6.00   I   Held by S.C.O.U.T. Healthcare Fund, L.P.   (1)
Warrant   4/15/2004   4/15/2014   Common Stock   40000   $6.00   I   Held by S.C.O.U.T. Healthcare Fund, L.P.   (1)

Explanation of Responses:
( 1)  Dr. Greer serves as the President and majority shareholder of the general partner of S.C.O.U.T. Healthcare Fund, L.P., the holder of these shares.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Greer Lawrence W
2525 WEST END AVE.
SUITE 950
NASHVILLE, TN 37203 		X



Signatures
Lawrence W. Greer by: /s/ Jean W. Marstiller, as Attorney-in-fact 8/10/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.